Humana (NYSE:HUM) 2026 Conference Summary Company Overview - **Company**: Humana Inc. - **Industry**: Healthcare and Medicare Advantage Key Themes and Commitments - Humana reaffirmed its commitment to achieving a stable Medicare Advantage (MA) margin of at least 3% and restoring earnings power by 2028, as stated during the Investor Day in June 2025 [2][3] - Adjustments to benefits will be necessary to accommodate the current medical cost trends and funding environment [3][12] Lifetime Value of Members - The concept of lifetime value is emphasized, indicating that the economic value of a member increases significantly from year one to year two, primarily due to lower retention costs and better member management [3][4] - A stable MA margin is essential for maximizing member retention and minimizing attrition [4][5] Membership Metrics - During the Annual Enrollment Period (AEP), over 1 million new members were added, with approximately 70% being switchers from other plans, which are generally more economically favorable in the first year [17][18] - Humana absorbed about 12% of plan exits, indicating a positive mix of new members coming from other plans rather than exits [18][19] - 70% of new members are enrolled in four-star or better contracts, and 75% are acquired through higher-quality sales channels [18][19] Sales Channel Strategy - Humana has focused on improving the quality of its sales channels by trimming lower-performing call centers and broker partners, which has led to a better membership mix [22] Margin Profiles and Member Engagement - The company expects to double margins despite headwinds from Star ratings, with a consistent mix of HMO and PPO plans compared to previous years [23][26] - Engagement initiatives have been enhanced, with proactive outreach to new members to improve their onboarding experience and overall satisfaction [54][56] Star Ratings and Operational Performance - Humana is optimistic about its Star Ratings performance, having made significant strides in operational metrics and member engagement [63][64] - Recent changes proposed by CMS to focus more on health outcomes rather than administrative metrics are supported by Humana, as they align with the company's ongoing efforts to improve quality [70][71] Part D and PDP Margins - Humana is guiding towards break-even margins for its Part D business, with expectations for more consistent profitability as the program stabilizes [72][74] - The company views its PDP as a strategic starter product that can lead to further engagement in MAPD plans [75] Regulatory Environment and Rate Notice - The company expressed concerns about the implications of the preliminary rate notice from CMS, emphasizing the need for adjustments to maintain benefits amidst rising costs [80][81] - Humana is actively engaging with policymakers to advocate for necessary changes that would benefit members [81] CenterWell and Acquisitions - Recent acquisitions in Florida are aimed at filling geographic gaps in Humana's CenterWell portfolio, enhancing operational fit and expanding the primary care footprint [102][103] - The company emphasizes that both the Medicare Advantage and CenterWell businesses must stand alone financially [106] Conclusion - Humana is strategically positioned to navigate the current healthcare landscape, focusing on member retention, quality improvement, and operational efficiency while adapting to regulatory changes and market dynamics. The company remains committed to its long-term financial goals and enhancing member value through targeted initiatives.

Financial Data and Key Metrics Changes - The company reported a fourth quarter adjusted diluted loss per share of $1.19, contributing to a full year 2025 adjusted diluted EPS of $2.08, which was slightly ahead of expectations outlined in the previous quarter [4][22] - The fourth quarter GAAP diluted loss per share was $2.24, including a $389 million net loss from the divestiture of the remaining Magellan business [22] - The company anticipates full year 2026 adjusted EPS to exceed $3, representing over 40% year-over-year growth [5][32] Business Line Data and Key Metrics Changes - Medicaid's health benefits ratio (HBR) improved to 93.0% in Q4, showing a 40 basis points sequential improvement and 190 basis points improvement from Q2 levels [6][22] - The Marketplace segment experienced a slight improvement in medical cost trends, with Q4 results better than expectations [10][24] - The Medicare segment delivered strong results, with fourth quarter performance in line with expectations, setting a solid foundation for 2026 [15][25] Market Data and Key Metrics Changes - The company closed 2025 with approximately 12.5 million Medicaid members, reflecting slight attrition [23] - Marketplace membership is expected to decline to around 3.5 million by the end of Q1 2026, down from 5.5 million in December [12][29] - Medicare Advantage revenue is projected to be flat from 2025 to 2026, with membership intentionally reduced [29] Company Strategy and Development Direction - The company is focused on restoring Medicaid business to sustainable profitability while maintaining quality outcomes for members [5][7] - There is a strong emphasis on leveraging data and technology, including AI, to enhance operational efficiency and member engagement [18][19] - The company aims to achieve break-even results in Medicare Advantage by 2027, with ongoing improvements in service and member experience [15][17] Management's Comments on Operating Environment and Future Outlook - Management acknowledged that 2025 was a challenging year but expressed confidence in the company's ability to execute against the 2026 outlook [20][21] - The company expects continued margin expansion opportunities while keeping members at the center of its operations [21] - Management highlighted the importance of proactive engagement with state partners to ensure program sustainability and address cost pressures [34][38] Other Important Information - The company ended 2025 with approximately $400 million in cash available for corporate use and reduced debt by $189 million, resulting in a debt-to-cap ratio of 46.5% [27] - The medical claims liability totaled $20.5 billion, representing 46 days in claims payable, a decrease of 2 days compared to the previous quarter [28] Q&A Session Summary Question: Medicaid rate expectation for 2026 - Management explained that the 4.5% rate expectation for Medicaid is based on constructive conversations with state partners and reflects a prudent assumption given the data available [33][34] Question: Trend comparison for Medicaid in 2025 - Management indicated that the 2025 trend was in the mid-6s, and the 2026 assumption of mid-4s is a net trend expectation, considering the elevated baseline and actions taken in the latter half of 2025 [35][36] Question: Confidence in Marketplace margin improvement - Management expressed confidence in margin improvement for the Marketplace segment due to effective repricing and repositioning strategies, as well as favorable membership dynamics observed during open enrollment [39][40] Question: Membership attrition in Medicaid - Management acknowledged slight attrition in membership and discussed the impact of state eligibility tightening and program changes on future membership [43][44] Question: Actuarial soundness lookback process - Management emphasized the importance of shortening the lookback period for actuarial soundness and maximizing the inclusion of recent data in rate adjustments [46][49] Question: Segment margins in 2026 guidance - Management provided insights into expected margins across segments, indicating opportunities for improvement while noting that long-term targets are still being assessed due to ongoing policy changes [51][52]